Clinical Trials Logo

Clinical Trial Summary

The primary purpose is to describe the pattern of Belatacept use at the time of transplant and up to three years post-transplantation for all Belatacept treated patients.


Clinical Trial Description

Time Perspective: Prospective design, Retrospective data collection and analysis ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01476943
Study type Observational
Source Bristol-Myers Squibb
Contact
Status Completed
Phase
Start date March 31, 2012
Completion date April 30, 2018

See also
  Status Clinical Trial Phase
Completed NCT01536379 - A Study of Belimumab in the Prevention of Kidney Transplant Rejection Phase 2
Recruiting NCT02279810 - Attitudes About Organ Transplantation N/A